NFE2L2 and chronic obstructive pulmonary disease: Thus, knowledge of Nrf2 is increasing exponentially, and the pathway is showing promise in preclinical studies as a target for the prevention and treatment of various diseases, such as cancer [13], chronic kidney disease [14], chronic obstructive pulmonary disease (COPD) [15], neurodegenerative disorders [16], and diabetes [17].